天順風能(002531.SZ):擬發行GDR募資不超24.20億元 用於德國50萬噸風電海工基地建設項目等
格隆匯7月18日丨天順風能(002531.SZ)公佈境外發行全球存託憑證新增境內基礎A股股份的發行預案,本次GDR擬在全球範圍內進行發售,擬面向合格國際投資者及其他符合相關規定的投資者發行。
本次發行GDR所代表的新增基礎證券A股股票,包括因任何超額配股權獲行使而發行的證券(如有),不超過本次發行前公司普通股總股本的15%;本次發行GDR募集資金總額不超過人民幣24.20億元(或等值外幣)。
本次公開發行可轉換公司債券募集資金總額不超過24.20億元(含本數),扣除發行費用後將17億元用於德國50萬噸風電海工基地建設項目、7.2億元補充流動資金項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.